We use cookies to make this site work. We'd also like to set optional cookies so we can understand how the site is used and improve it. We will not set optional cookies unless you accept them. You can change your choice at any time from the Cookie settings link in the footer.
Strictly necessary cookies
These cookies are required for the site to work. They store your cookie preferences and keep your session secure. They are exempt from consent under PECR Regulation 6(4) because they are essential to deliver the service you have requested.
Optional cookies
Optional cookies help us understand how the site is used and provide additional features such as analytics, accessibility tools and translation. We will only set them if you accept.
Essential Thrombocythaemia
Do you have Essential Thrombocythaemia (ET)?
- Are you 18 years old or over?
- Are you or have you in the past been resistant or intolerant to hydroxycarbamide (hydroxyurea) treatment?
Consider your options with the VECTRA study
To learn more about the study or to find out if the study could be right for you, please complete this online form
About the study
- The study aims to evaluate the safety and effectiveness of dencatistat (STP938).
- You would be given capsule(s) of dencatistatto take once daily.
- Based on other studies, dencatistat may be a good option for patients with ET.
If you think the study might be right for you
- You will be asked to attend a screening visit at the clinic.
- During this visit you will be asked some questions about your general health.
- You will be asked to provide blood and urine samples as well as have some examinations to see if you are suitable to take part in this research study.
Published: Apr 22, 2026